1. Home
  2. HOTH vs WATT Comparison

HOTH vs WATT Comparison

Compare HOTH & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • WATT
  • Stock Information
  • Founded
  • HOTH 2017
  • WATT 2012
  • Country
  • HOTH United States
  • WATT United States
  • Employees
  • HOTH N/A
  • WATT N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • WATT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • HOTH Health Care
  • WATT Technology
  • Exchange
  • HOTH Nasdaq
  • WATT Nasdaq
  • Market Cap
  • HOTH 8.3M
  • WATT 9.1M
  • IPO Year
  • HOTH 2019
  • WATT 2014
  • Fundamental
  • Price
  • HOTH $0.98
  • WATT $0.31
  • Analyst Decision
  • HOTH Strong Buy
  • WATT Strong Buy
  • Analyst Count
  • HOTH 4
  • WATT 2
  • Target Price
  • HOTH $4.75
  • WATT $2.25
  • AVG Volume (30 Days)
  • HOTH 623.8K
  • WATT 603.9K
  • Earning Date
  • HOTH 05-13-2025
  • WATT 05-13-2025
  • Dividend Yield
  • HOTH N/A
  • WATT N/A
  • EPS Growth
  • HOTH N/A
  • WATT N/A
  • EPS
  • HOTH N/A
  • WATT N/A
  • Revenue
  • HOTH N/A
  • WATT $768,000.00
  • Revenue This Year
  • HOTH N/A
  • WATT $1,028.91
  • Revenue Next Year
  • HOTH N/A
  • WATT N/A
  • P/E Ratio
  • HOTH N/A
  • WATT N/A
  • Revenue Growth
  • HOTH N/A
  • WATT 62.02
  • 52 Week Low
  • HOTH $0.58
  • WATT $0.26
  • 52 Week High
  • HOTH $3.80
  • WATT $2.70
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 42.23
  • WATT 45.03
  • Support Level
  • HOTH $1.01
  • WATT $0.26
  • Resistance Level
  • HOTH $1.19
  • WATT $0.31
  • Average True Range (ATR)
  • HOTH 0.07
  • WATT 0.03
  • MACD
  • HOTH -0.01
  • WATT 0.00
  • Stochastic Oscillator
  • HOTH 23.82
  • WATT 44.55

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

About WATT Energous Corporation

Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.

Share on Social Networks: